Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder - Concepedia

Concepedia

Publication | Closed Access

Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

156

Citations

0

References

2005

Year

Lenard A. Adler, Thomas Spencer, Denái R. Milton, Rodney J. Moore, David Michelson

The Journal of Clinical Psychiatry

Abstract

The results of this interim analysis of an ongoing, open-label study of adults with ADHD support the long-term efficacy, safety, and tolerability of atomoxetine for the treatment of adult ADHD.